Edick Paul R has filed 3 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 35200 shares of Vistagen Therapeutics, Inc. ($VTGN) on October 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 27, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Edick Paul R | Not found | A | Stock Option (Right to Buy) | 35200 | $0.00 | 35,200.0000 | 35,749,160 | 9999.99% | 0.10% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Edick Paul R | See Remarks | A | Common Stock | 1500000 | $0.00 | 3,821,494.0000 | 137,674,857 | 64.61% | 1.09% |
| Jan. 31, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Edick Paul R | See Remarks | A | Stock Appreciation Right | 500000 | $0.00 | 500,000.0000 | 137,674,857 | 9999.99% | 0.36% |